PaySign, Inc. reaffirmed earnings guidance for the year 2023. The company is expecting continued growth in its plasma and pharma patient affordability businesses and are on track to meet its revenue guidance it provided in March, principally revenue to be in the range of $44.0 million to $46.0 million.